I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer. I-Mab has established operations in Rockville, ...

European equities traded in the US as American depositary receipts were lower late Friday morning, declining 0.92% to 1,427.19 on the S&P Europe Select ADR Index, which is set to close out the week ...

American depository receipts of Yiren Digital fell after the company posted a lower profit in the fourth quarter, dragged down by higher upfront provisions as loan volumes increased, as well as more ...

Joyy's American depositary receipts fell after the video social-media platform operator swung to a fourth-quarter loss and missed revenue estimates. ADRs were down 9.7% to $42.37 in late-morning ...

The parent company behind Temu disappointed investors with revenue that missed estimates, as consumer activity in China ...

PDD Holdings Inc.’s revenue grew at a slower-than-expected pace of 24% after intensifying domestic competition and US tariffs ...

Shares in XPeng slumped in Hong Kong amid profit-taking, a day after it reported solid fourth-quarter results.

Pfizer is wrapping up its lucrative goodbye to Haleon, raising approximately $3.3 billion by offloading its remaining 7.3% ...

BYD hit a record high market cap thanks to its latest innovation, while a market crash in Elon Musk's auto company has lined ...